Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.1M Buy
+583,300
New +$29.8M 0.04% 339
2024
Q2
– Sell
-41,852
Closed -$1.79M – 959
2024
Q1
$1.79M Hold
41,852
– – ﹤0.01% 786
2023
Q4
$1.55M Buy
+41,852
New +$1.5M ﹤0.01% 794
2020
Q1
– Sell
-253,440
Closed -$14.9M – 925
2019
Q4
$14.9M Buy
253,440
+960
+0.4% +$53.4K 0.04% 383
2019
Q3
$13.5M Hold
252,480
– – 0.03% 388
2019
Q2
$12.6M Buy
+252,480
New +$12.7M 0.03% 459

Other funds holding GSK

Aberdeen Group's GSK Position: Q3 2026 in Review

Aberdeen Group opened a new position in GSK (GSK) in Q3 2026: 583,300 shares worth $28.1M. The stake represents 0.04% of the portfolio and ranks #339 among its holdings. This is a return to the name: Aberdeen Group previously reported a position in GSK as recently as Q1 2024.

Aberdeen Group first reported a position in GSK in Q2 2019 and has held it in 6 quarters since. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Aberdeen Group held 583,300 shares of GSK worth $28.1M as of Q3 2026.
  • GSK was a new Aberdeen Group position in Q3 2026.
  • GSK made up 0.04% of Aberdeen Group's portfolio in Q3 2026, its #339 holding.
  • Aberdeen Group first reported a position in GSK in Q2 2019 and has held it in 6 quarters since.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Aberdeen Group's 13F filing for Q3 2026, filed 6 Nov 2026.